Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors

• Daniel V Kalinovsky,
• Alexey V Kibardin,
• Irina V Kholodenko,
• Elena V Svirshchevskaya,
• Igor I Doronin,
• Mariya V Konovalova,
• Maria V Grechikhina,
• Fedor N Rozov,
• Sergey S Larin,
• Sergey M Deyev,
• Roman V Kholodenko

Affiliations

Daniel V Kalinovsky

Department of Immunology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia

Alexey V Kibardin

Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia

Irina V Kholodenko

Orekhovich Institute of Biomedical Chemistry, Moscow, Russia

Elena V Svirshchevskaya

Department of Immunology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia

Igor I Doronin

Department of Immunology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia

Mariya V Konovalova

Department of Immunology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia

Maria V Grechikhina

Department of Immunology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia

Fedor N Rozov

Lomonosov Moscow State University, Moscow, Russia

Sergey S Larin

Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia

Sergey M Deyev

Department of Immunology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia

Roman V Kholodenko

Department of Immunology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia